MedTech executive leader and strategist, John Tushar, has joined the BiotechExec Senior Advisor Executive Team (The SEAT).

Tushar is a global medical device executive with over 25 years of experience leading public companies, and who has also worked with several venture-backed startups in the medical device, healthcare IT, and surgical and diagnostics fields. Throughout John’s career, he has managed acquisitions of up to over $1BN, raised over $250MM for operating capital and managed teams over 2,500 people. “John is a highly sought out global business strategist. With expertise in operational leadership, mergers and acquisitions, portfolio management, and strategies for commercial execution of new products in the complex and rapidly evolving healthcare products landscape, we know that he will have an enormous impact on any BiotechExec client,” said Russell Allen, CEO of BiotechExec.

Read More – https://biotechexec.com/john-tushar/

“BiotechExec is multi-dimensional in that it can source and provide fractional executive leadership through its network, and now the Advisory Team can address the additional needs of start-ups, established private and public enterprises seeking growth through expansion and/or new services, etc. I’m excited to be part of this team to help innovative companies bring life-changing and life-saving products to patients,” said Tushar.

Together with his fellow Senior Executive Advisory Team (SEAT) members, John will work with Biotech Exec’s clients to define the scope of work that will bring the greatest benefit to their organization. Our Senior Advisors will engage the members of our global
network best equipped to deliver this scope and build commercial success to life science companies – to benefit their shareholders and customers, for the future of global healthcare.